---
title: "Pharming Group Unit Extends Offer Period for Abliva Takeover, Secures 87.7% Stake"
date: "2025-02-09 18:22:01"
summary: "Pharming Group's Pharming Technologies extended its acceptance period for Swedish biotechnology company Abliva (, ABLI/BTA.ST) shareholders to Feb. 20 after securing an 87.7% stake. The 0.45 krona-per-share offer, which is now unconditional, was made by the Dutch biopharmaceutical company's subsidiary in December 2024, according to a Feb. 7 release. The..."
categories:
  - "MT Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "MT Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Pharming Group's Pharming Technologies extended its acceptance period for Swedish biotechnology company Abliva (, ABLI/BTA.ST) shareholders to Feb. 20 after securing an 87.7% stake.

The 0.45 krona-per-share offer, which is now unconditional, was made by the Dutch biopharmaceutical company's subsidiary in December 2024, according to a Feb. 7 release.

The company noted that it will initiate a compulsory acquisition of shares if it amasses more than a 90% shareholding in Abliva.

[MT Newswires](https://www.tradingview.com/news/mtnewswires.com:20250209:G2465252:0/)
